Key events, in time order
Company raises full-year guidance on surging testing demand, though lower-margin deals and rising costs may temper gains.
None yet
None yet
Quest Diagnostics (DGX) is mentioned as one of many stocks that reached new 52-week highs, indicating positive price momentum.
Main discussion
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
Hold (sector percentile 35) — value B, growth B-, profitability C+, momentum B-, revisions C+. Updated daily, sector-relative, identical for every user.
